Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary <em>In Vivo</em> Report

Paolo Giuseppe Limoli; Enzo Maria Vingolo; Celeste Limoli; Sergio Zaccaria Scalinci; Marcella Nebbioso

doi:10.3791/56469

/

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary <em>In Vivo</em> Report

JoVE Journal
Medycyna

Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.

JoVE Journal Medycyna

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

10,056 Views

•

10:24 min

•

February 12, 2018

DOI:

10.3791/56469-v

DOI:

10.3791/56469-v

•

10:24 min

February 12, 2018

•

3 Views

Paolo Giuseppe Limoli¹, Enzo Maria Vingolo², Celeste Limoli¹, Sergio Zaccaria Scalinci³, Marcella Nebbioso⁴

¹Low Vision Research Centre of Milan, ²Department of Ophthalmology, A. Fiorini Hospital,Sapienza University of Rome, ³Glaucoma and Low Vision Study Center, Department of General Surgery and Organ Transplants,University of Bologna, ⁴Department of Sense Organs, Faculty of Medicine and Odontology,Sapienza University of Rome

Transkrypcja

Podsumowanie

The goal of this study is to assess whether the suprachoroidal graft of adipose-derived stem cells included in the stromal vascular fraction and platelets derived from platelet-rich plasma by the Limoli Retinal Restoration Technique can improve visual acuity and retinal sensitivity responses in eyes affected by dry age-related macular degeneration.